We are very happy to see the results of our latest research online at BioRXiv: https://www.biorxiv.org/content/10.1101/2024.07.22.604613v1. The visual code that can be achieved by targeting ON bipolar cells with optogenetic therapy is much richer as when targeting retinal ganglion cells! A great collaborative work led by our colleagues in Manchester!